Microcephaly Panel
New York
Approved
Genes
Conditions
- Microcephaly
- Primary AR microcephaly
- Rubinstein-Taybi syndrome (RSTS)
- Warburg Micro Syndrome
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Establish the type of microcephaly and cause in order to provide information regarding prognosis, management and recurrence risk.
- Testing of at-risk relatives for specific known pathogenic variant(s) previously identified in an affected family member
- Prenatal diagnosis for known familial pathogenic variant(s) in at-risk pregnancies
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
689
CPT Codes*
81404x1, 81405x2, 81406x2, 81407x1, 81302x1, 81304x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.
Test Documents
Billing
Targeted Variant Testing